Thomas Nerreter

17PUBLICATIONS
76CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyReceptors and membrane biologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 03, 2026
Novel CAR T cell blend targeting PDPN and GD2 to overcome glioblastoma heterogeneity.

|Apr 10, 2026
Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination.

Linda Warmuth, Sarah Dötsch, Manuel Trebo

|Mar 31, 2026
Loss of GPRC5D enhances the proliferative capacity and competitive fitness of myeloma upon anti-GPRC5D immunotherapy.

Umair Munawar, Johanna Thurner, Silvia Nerreter

|Feb 04, 2026
Single-molecule localization microscopy reveals the molecular organization of endogenous membrane receptors.

Patrick Eiring, Maximilian J Steinhardt, Nele Bauer

|Sep 10, 2025
Plasmapheresis facilitates soluble BCMA clearance and contributes to reversing primary resistance to anti-BCMA immunotherapy in multiple myeloma.

Sven Neubert, Umair Munawar, Julia Mersi

|Jan 09, 2025
Decoding the molecular interplay of CD20 and therapeutic antibodies with fast volumetric nanoscopy.

Arindam Ghosh, Mara Meub, Dominic A Helmerich

Pageof 3

Frequent Collaborators

7 joint publications

Michael Hudecek

4 joint publications

Sophia Danhof

4 joint publications

K Martin Kortüm

4 joint publications

Markus Sauer